{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-104901","form_type":"8-K","ticker":"REGN","cik":"0000872589","company_name":"REGENERON PHARMACEUTICALS, INC.","filed_at":"2022-10-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.803037+00:00","generated_at":"2026-06-23T06:12:20.539463+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Regeneron elects Craig B. Thompson, M.D. as director; board expands to 13 members","bullets":["Dr. Craig B. Thompson elected as director effective October 3, 2022; board expands from 12 to 13.","Appointed to Technology Committee; term runs until 2023 Annual Shareholder Meeting.","Compensation follows standard non-employee director practices described in April 21, 2022 proxy.","No arrangement or understanding with any other person regarding his selection as director."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-104901","json":"https://secwatch.observer/filing/0001104659-22-104901.json","markdown":"https://secwatch.observer/filing/0001104659-22-104901.md","text":"https://secwatch.observer/filing/0001104659-22-104901.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/872589/000110465922104901/0001104659-22-104901-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/872589/000110465922104901/tm2227120d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T06:12:20.539463+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"551c4ee778","claim":"Craig B. Thompson was elected as Director at REGENERON PHARMACEUTICALS, INC..","evidence_excerpt":"On October 3, 2022, the board of directors (the “ Board ”) of Regeneron Pharmaceuticals, Inc. (the “ Company ”) elected Craig B. Thompson, M.D. as a director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/872589/000110465922104901/0001104659-22-104901-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}